Capital Square 1031 has acquired a portfolio of nine medical office buildings located in five states. Each property is 100 percent leased to Fresenius Medical Care, a provider of dialysis services and products.
“This is a diversified portfolio of well-located medical clinics with new 15-year net leases guaranteed by Fresenius Medical Care Holdings, an investment-grade company,” said Louis Rogers, founder CEO of Capital Square 1031. “We believe that medical real estate is a stable and recession-resistant asset class. This healthcare-related portfolio is an attractive opportunity for investors seeking a safe investment because dialysis is a necessary and recurring medical treatment for more than 2.5 million Fresenius patients worldwide. By expanding Capital Square’s relationship with Fresenius, we are able to help a growing number of investors gain access to medical properties using the DST structure.”
Located in Texas, Tennessee, New York, Michigan and Mississippi, the portfolio includes the following properties:
- 5000 Campus Dr., a 10,640-square-foot building in Fort Worth, Texas
- 9449 Grogans Mill Road, a 6,865-square-foot building in The Woodlands, Texas
- 825–833 Dalworth St., a 9,150-square-foot building in Grand Prairie, Texas
- 222 E. Sinton St., an 8,000-square-foot building in Sinton, Texas
- 3600 Netherland Inn Road, a 7,028-square-foot building in Kingsport, Tenn.
- 113 E. C Thurmond Cove, a 4,600-square-foot building in Martin, Tenn.
- 220 Crystal Run Road, a 10,000-square-foot building in Middletown, N.Y.
- 5205 McAuley Dr., a 7,800-square-foot building in Ypsilanti, Mich.
- 241 Meadowlane St., a 3,215-square-foot building in Eupora, Miss.
“With approximately 18 percent of the U.S. gross domestic product, as reported by the Centers for Medicare and Medicaid Services, and resistance to economic downturns, healthcare has proven to be a growing industry and a premier real estate asset class,” Rogers added.
As of May 2, 2018, Capital Square 1031 oversees a growing national portfolio of 67 real estate assets valued at approximately $670 million (based on aggregate investment cost).
